Effects of dietary cholesterol and triglycerides on lipid concentrations in liver, plasma, and bile

• Published in: Lipids 1997-02, Vol.32 (2), p.163-172
• Main Authors: Booker, M.L, LaMorte, W.W, Beer, E.R, Hopkins, S.R
• Format: Article
• Language: English
• Subjects: Animals; Bile - metabolism; Cholelithiasis - metabolism; Cholesterol; Cholesterol - metabolism; Cholesterol, Dietary - metabolism; Diet; diet-related diseases; Dietary Fats - metabolism; Female; human health and safety; human nutrition; Ingestion; Lipids; Liver - metabolism; medicine; nutrition physiology; Phospholipids - metabolism; Plasma; Risk factors; Sciuridae; Taurocholic Acid - metabolism; Taurodeoxycholic Acid - metabolism; Triglycerides; Triglycerides - metabolism
• ISSN: 0024-4201; 1558-9307
• DOI: 10.1007/s11745-997-0021-4

Dietary cholesterol (CHL) and triglycerides (TG) can influence plasma, hepatic, and biliary lipid composition, but effects on lipids in these three compartments during the early stages of CHL gallstone formation have not been studied in parallel. We fed prairie dogs diets containing one of four tes oils (safflower, coconut, olive, or menhaden) at either 5 or 40% of calories, in the presence of 0 or 0.34% CHL, for 3 wk. In the absence of dietary CHL, increases in dietary TG produced 50–200% increases in the concentrations of biliary CHL and hepatic cholesteryl ester (CE), while the concentrations of hepatic free CHL (FC) as well as plasma FC and CE remained relatively unchanged. Increasing dietary CHL to 0.34% resulted in increases in hepatic FC of approximately 50% for all four fats regardless of whether they were supplied at 5 or 40% of calories. CHL supplementation caused more pronounced increases in biliary CHL (200–400%), hepatic CE (50–200%), plasma FC (up to 100%), and plasma CE (up to 150%), and these increases were exacerbated by concurrent supplementation of dietary fat and CHL (biliary CHL: 300–700%; hepatic CE: 100–250%; plasma FC: up to 165%; plasma CE: 100–350%). These results indicate that enhanced secretion of biliary CHL and, to a lesser extent, increased synthesis of hepatic CE, may be primary mechanisms for maintaining the hepatic FC pool. Furthermore, dietary CHL and high levels of fat intake are independent risk factors for increasing biliary CHL concentrations, and adverse effects on lipid concentrations in plasma and bile tend to be exacerbated by ingestion of diets rich in both fat and CHL.